A kind of random copolymer based on polyphosphate, its preparation method and application

A technology of random copolymers and polyphosphate esters, which can be used in medical preparations, drug combinations, and pharmaceutical formulations of non-active ingredients, and can solve problems such as no reports on phosphate ester copolymers.

Inactive Publication Date: 2016-02-03
SUZHOU UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] In the prior art, there is no report on phosphate copolymers modified with galactose groups targeting liver cells

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of random copolymer based on polyphosphate, its preparation method and application
  • A kind of random copolymer based on polyphosphate, its preparation method and application
  • A kind of random copolymer based on polyphosphate, its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0050] Example 1: Random copolymer Poly(CL) with side groups having carbon-carbon double bonds 26 - co -OPEA 6 )Synthesis

[0051] Initiation of the monomer ε-caprolactone (ε-CL) and the phosphate monomer 2-acrylate ethyloxy-2-oxo-1,3,2-dioxaphospholane (OPEA) with benzyl alcohol Ring-opening copolymerization to prepare a random copolymer Poly(CL 26 - co -OPEA 6 ).

[0052] Dry the branched round-bottomed flask with a stirrer in an oven at 120°C for at least 24 hours, plug it with a glass stopper, connect it to an oil pump through a latex tube and pump it to room temperature, then introduce high-purity argon gas, and then evacuate it. After repeating three times, it was filled with argon.

[0053] Benzyl alcohol (0.10 g, 0.93 mmol), ε-caprolactone (ε-CL) (4.51 g, 39.43 mmol), OPEA (2.24 g, 10.08 mmol), toluene (10 mL) were sequentially injected from the branch tube with a dry syringe and stannous octoate [Sn(Oct) 2 ] (12 mg). After the reaction bottle was filled with...

Embodiment 2

[0054] Example 2: Random copolymer Poly[CL with carboxyl groups in side groups 26 - co -(OPEA -COOH ) 6 ]Synthesis

[0055] The Poly(CL of embodiment one preparation 26 - co -OPEA 6 ) and the thiol reagent mercaptopropionic acid under the irradiation of 365nm ultraviolet light to carry out the mercapto-alkene addition reaction to obtain the random copolymer Poly[CL 26 - co -(OPEA -COOH ) 6 ].

[0056] Add Poly(CL 26 - co -OPEA 6 ) (0.52g, 0.12mmol), add chloroform to dissolve, then add mercaptopropionic acid (0.12g, 1.08mmol) and photoinitiator benzoin dimethyl ether (DMPA) (1mg) in turn, and place it under a 365nm ultraviolet lamp to react 30 minutes. Shake the reaction dish gently every 5 minutes during the reaction to complete the reaction. After the reaction was completed, the reaction mixture was precipitated with 100 mL of ice anhydrous ether, and the ether was poured off to obtain a colorless viscous substance. Dry the crude product in a vacuum oven for ...

Embodiment 3

[0057] Example 3: Random copolymer Poly[CL with galactose groups in side groups 26 - co -(OPEA -Gal ) 6 ]Synthesis

[0058] Using galactosamine hydrochloride as the amino reagent, in 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC·HCl) and N-hydroxysuccinimide (NHS ) in the presence of Poly[CL 26 - co -(OPEA -COOH ) 6 ] carboxyl group to undergo amidation reaction to obtain a random copolymer Poly[CL with liver cell targeting and biodegradability 26 - co -(OPEA -Gal ) 6 ].

[0059] In a 25mL dry three-necked flask, add Poly[CL 26 - co -(OPEA-COOH) 6 ] (0.23g, 0.05mmol), 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC·HCl) (0.16g, 0.83mmol) and N-hydroxysuccinyl Imine (NHS) (0.08 g, 0.69 mmol), dissolved in 10 mL of dry dimethyl sulfoxide (DMSO), was activated for 12 h. Triethylamine (0.07g, 0.69mmol) and galactosamine hydrochloride (0.11g, 0.51mmol) were dissolved in 5mL of DMSO, and added dropwise to the reaction bottle. After the...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention discloses a copolymer based on polyphosphate, its preparation method and application. The present invention first utilizes ring-opening polymerization of cyclic phosphate monomers and aliphatic cyclic ester monomers to obtain random copolymers with carbon-carbon double bonds in side groups; -ene addition to obtain a random copolymer with a carboxyl group in the side group; finally, the carboxyl group is amidated by galactosamine hydrochloride to obtain a galactose-modified random copolymer. The galactose group on the hydrophilic segment of this random copolymer can be specifically recognized by the asialoglycoprotein receptor on the liver cell membrane, making the drug targeted to the liver cell; at the same time, the polyphosphate The structural unit can be rapidly degraded under weakly acidic conditions to dissociate the micelles. When the carrier reaches the tumor or diseased tissue, it can quickly release the drug loaded in the micelle core under the acidic environment in the cell. Good application prospects.

Description

technical field [0001] The invention belongs to the field of biomedical polymer materials, and in particular relates to a random copolymer based on polyphosphate, its preparation method and its application as a liver cell targeting drug carrier. Background technique [0002] Chemotherapy, which is currently clinically used in cancer treatment, is to inject anticancer drugs into the whole body through intravenous injection. Although this method can inhibit cancer cells, it has great damage to normal cells. The development of nanotechnology provides a new method for the effective delivery of anticancer drugs to tumors. Integrating drug molecules into nanocarriers through encapsulation, covalent bonding or adsorption can achieve drug solubilization, protect drug activity, and reduce drug side effects. At the same time, targeting ligand molecules can be used to enhance target cells. The ability to take drugs. [0003] Targeting drug delivery system (TDDS) refers to a drug deli...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityPatents(China)
IPC IPC(8): C08G79/04C08G63/692C08G63/08A61K47/34A61P35/00
Inventor倪沛红陶云锋何金林张明祖
OwnerSUZHOU UNIV